SCHEMBL1950506

SCHEMBL1950506

CC(C)OC(=O)COc1cc(F)cc(C=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
TP53 P04637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
PTGDR Q13258 1/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
ESR1 P03372 1/20 0.34
KMT2A Q03164 3/20 0.33
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1949826 0.79 MAPT (0.54) MAPTTP53RXFP1ALDH1A1KDM4E
SCHEMBL11784059 0.78 MAPT (0.63) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL29950754 0.77 ALDH1A1 (0.41) ALDH1A1KDM4EESR1MAOAMAOB
SCHEMBL24806561 0.74 MAPT (0.67) MAPTALDH1A1KMT2AMAOAMAOB
SCHEMBL1950408 0.74 ALDH1A1 (0.45) MAPTALDH1A1HPGDKDM4EESR1
SCHEMBL3230270 0.71 KAT6A (0.40) MAPTALDH1A1HPGDKMT2AMAOA
SCHEMBL12968136 0.70 ALDH1A1 (0.45) MAPTALDH1A1HPGDKDM4EMAOA
SCHEMBL29935896 0.69 MAOA (0.40) MAPTALDH1A1HPGDKMT2AMAOA
SCHEMBL25226906 0.69 GAA (0.53) MAPTTP53ALDH1A1HPGDKDM4E
SCHEMBL28623170 0.69 MAOA (0.40) MAPTALDH1A1HPGDKMT2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507237-A1 IMIDAZOQUINOLINES WHICH ACT VIA TOLL - LIKE RECEPTORS (TLR) Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-10-10 EP disclosed
WO-2011068233-A1 IMIDAZOQUINOLINES WHICH ACT VIA TOLL - LIKE RECEPTORS (TLR) DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-06-09 WO disclosed
US-20110136801-A1 Novel Compounds DAINIPPON SUMITOMO PHARMA CO. LTD. (JP) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136801-A1 Novel Compounds C1R, RB1, CNKSR1 MAPT 3434/4885TP53 862/4885RXFP1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.